Latest Regulatory Compliance News

ASPI Isotopes Inc. and Renergen Limited have received regulatory clearance to proceed with their Scheme of Arrangement, setting a detailed timetable for share suspensions, listings, and settlements complicated by cross-border processes.

Epsilon Healthcare Limited has unveiled a comprehensive pre-reinstatement disclosure, highlighting improved financial health and a strategic growth plan focused on operational stability and expansion.

Jumbo Interactive will subcontract with Brightstar Lottery PLC to deliver key components of Lotterywest’s new gaming and digital platform, marking a significant collaboration in the lottery technology space.

TasFoods Ltd has secured shareholder approval to sell its Pyengana Dairy business and to execute a selective buy-back of nearly 50 million shares, marking a pivotal moment in its strategic reshaping.

Native Mineral Resources has secured the Estimated Rehabilitation Cost decision, unlocking mining activities at the Podosky site with drilling set for January 2026 and ore processing targeted by late February.

Netwealth Group Limited will compensate members affected by the First Guardian Master Fund collapse with $101 million, impacting its 1H26 profit but aiming to restore member confidence swiftly.

Minbos Resources has postponed the start of its Share Purchase Plan as it awaits a critical ASX decision on a waiver application, leaving the timetable uncertain.

Locate Technologies has completed its redomiciliation from Australia to New Zealand, establishing Locate NZ as the new parent company and appointing MUFG Pension & Market Services as its share registry provider.

ECS Botanics is strategically preparing for entry into the US medicinal cannabis market, leveraging its EU-GMP certification and proprietary genetics amid evolving regulatory landscapes.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Centrepoint Alliance forecasts a robust 13% increase in EBITDA for the first half of FY26, driven by strong adviser recruitment and platform scaling, cementing its position as the second-largest licensee in Australia.

Fiducian Group’s subsidiary Fiducian Investment Management Services Limited has filed a defence after ASIC initiated civil proceedings alleging misleading disclosure and compliance failures related to a managed fund.